These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22576620)

  • 41. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis.
    Bogatkevich GS; Ludwicka-Bradley A; Highland KB; Hant F; Nietert PJ; Singleton CB; Feghali-Bostwick CA; Silver RM
    Arthritis Rheum; 2007 Jul; 56(7):2432-42. PubMed ID: 17599773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.
    Ogawa F; Shimizu K; Hara T; Muroi E; Komura K; Takenaka M; Hasegawa M; Fujimoto M; Takehara K; Sato S
    Arch Dermatol Res; 2010 Jan; 302(1):27-35. PubMed ID: 19844733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients.
    Satoh M; Kuwana M; Ogasawara T; Ajmani AK; Langdon JJ; Kimpel D; Wang J; Reeves WH
    J Immunol; 1994 Dec; 153(12):5838-48. PubMed ID: 7989779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
    Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
    Front Immunol; 2021; 12():786039. PubMed ID: 34956217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
    Gourh P; Arnett FC; Assassi S; Tan FK; Huang M; Diekman L; Mayes MD; Reveille JD; Agarwal SK
    Arthritis Res Ther; 2009; 11(5):R147. PubMed ID: 19799786
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Gourh P; Safran SA; Alexander T; Boyden SE; Morgan ND; Shah AA; Mayes MD; Doumatey A; Bentley AR; Shriner D; Domsic RT; Medsger TA; Ramos PS; Silver RM; Steen VD; Varga J; Hsu V; Saketkoo LA; Schiopu E; Khanna D; Gordon JK; Kron B; Criswell LA; Gladue H; Derk CT; Bernstein EJ; Bridges SL; Shanmugam VK; Kolstad KD; Chung L; Kafaja S; Jan R; Trojanowski M; Goldberg A; Korman BD; Steinbach PJ; Chandrasekharappa SC; Mullikin JC; Adeyemo A; Rotimi C; Wigley FM; Kastner DL; Boin F; Remmers EF
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):552-562. PubMed ID: 31871193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-C1q autoantibodies are frequently detected in patients with systemic sclerosis associated with pulmonary fibrosis.
    Liaskos C; Rentouli S; Simopoulou T; Gkoutzourelas A; Norman GL; Brotis A; Alexiou I; Katsiari C; Bogdanos DP; Sakkas LI
    Br J Dermatol; 2019 Jul; 181(1):138-146. PubMed ID: 30875084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.
    Mejia Otero C; Assassi S; Hudson M; Mayes MD; Estrada-Y-Martin R; Pedroza C; Mills TW; Walker J; Baron M; Stevens W; Proudman SM; Nikpour M; Mehra S; Wang M; Fritzler MJ; ; ;
    J Rheumatol; 2017 Jun; 44(6):799-805. PubMed ID: 28365584
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
    Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
    Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
    Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
    Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature.
    Gelber AC; Manno RL; Shah AA; Woods A; Le EN; Boin F; Hummers LK; Wigley FM
    Medicine (Baltimore); 2013 Jul; 92(4):191-205. PubMed ID: 23793108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.
    Sujau I; Ng CT; Sthaneshwar P; Sockalingam S; Cheah TE; Yahya F; Jasmin R
    Int J Rheum Dis; 2015 May; 18(4):459-65. PubMed ID: 24618222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis.
    Low AH; Johnson SR; Lee P
    J Rheumatol; 2009 Apr; 36(4):787-93. PubMed ID: 19228652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.
    Yi L; Wang JC; Guo XJ; Gu YH; Tu WZ; Guo G; Yang L; Xiao R; Yu L; Mayes MD; Assassi S; Jin L; Zou HJ; Zhou XD
    Int J Immunopathol Pharmacol; 2013; 26(2):473-478. PubMed ID: 23755762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.
    Beall AD; Nietert PJ; Taylor MH; Mitchell HC; Shaftman SR; Silver RM; Smith EA; Bolster MB
    J Rheumatol; 2007 Jun; 34(6):1277-82. PubMed ID: 17516621
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-RNPC-3 antibody predicts poor prognosis in patients with interstitial lung disease associated to systemic sclerosis.
    Callejas-Moraga EL; Guillén-Del-Castillo A; Perurena-Prieto J; Sanz-Martínez MT; Fonollosa-Pla V; Lorite-Gomez K; Severino A; Bellocchi C; Beretta L; Mahler M; Simeón-Aznar CP
    Rheumatology (Oxford); 2021 Dec; 61(1):154-162. PubMed ID: 33742673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.